Literature DB >> 9269055

Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period.

W A Keitel1, T R Cate, R B Couch, L L Huggins, K R Hess.   

Abstract

Some reports have suggested that influenza virus vaccine is less effective in persons that have received prior annual vaccination(s) than in those receiving it for the first time. This issue was addressed by evaluating the efficacy of annual influenza vaccinations over a 5 year period in healthy adults employing commercially-available, inactivated whole-virus vaccine. Influenza vaccination had minimal effects on overall respiratory illnesses during epidemic periods. However, it reduced influenza virus shedding by an average of 38.8% and conferred protection against influenza virus infection during each epidemic. Some variation in infection rates were noted between vaccine groups given one or more than one annual immunization, and between years, but no consistent pattern of differences was noted in relation to number of successive years of vaccination. These results suggest that the current recommendation for annual influenza vaccination of persons at special risk of serious disease and complications is appropriate, but that continued efforts to improve the effectiveness of our prophylactic measures against influenza are needed.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9269055     DOI: 10.1016/s0264-410x(97)00003-0

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  67 in total

1.  Variable efficacy of repeated annual influenza vaccination.

Authors:  D J Smith; S Forrest; D H Ackley; A S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

2.  Effects of prior influenza virus vaccination on maternal antibody responses: Implications for achieving protection in the newborns.

Authors:  Lisa M Christian; Chloe Beverly; Amanda M Mitchell; Erik Karlsson; Kyle Porter; Stacey Schultz-Cherry; Octavio Ramilo
Journal:  Vaccine       Date:  2017-08-01       Impact factor: 3.641

3.  Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.

Authors:  Adrian J Reber; Tatiana Chirkova; Jin Hyang Kim; Weiping Cao; Renata Biber; David K Shay; Suryaprakash Sambhara
Journal:  Aging Dis       Date:  2011-09-30       Impact factor: 6.745

4.  Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study.

Authors:  Corina Nailescu; Xiyan Xu; Hong Zhou; Henrietta Hall; Amy C Wilson; Jeffrey D Leiser; Deepa H Chand; Rudolph P Valentini; Diane Hebert; John D Mahan
Journal:  Pediatr Nephrol       Date:  2010-12-22       Impact factor: 3.714

5.  Repeated influenza vaccination of healthy children and adults: borrow now, pay later?

Authors:  F Carrat; A Lavenu; S Cauchemez; S Deleger
Journal:  Epidemiol Infect       Date:  2006-02       Impact factor: 2.451

6.  Quantifying influenza vaccine efficacy and antigenic distance.

Authors:  Vishal Gupta; David J Earl; Michael W Deem
Journal:  Vaccine       Date:  2006-01-19       Impact factor: 3.641

7.  Non-traditional settings for influenza vaccination of adults: costs and cost effectiveness.

Authors:  Lisa A Prosser; Megan A O'Brien; Noelle-Angelique M Molinari; Katherine H Hohman; Kristin L Nichol; Mark L Messonnier; Tracy A Lieu
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

8.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.

Authors:  Suzanne E Ohmit; Mark G Thompson; Joshua G Petrie; Swathi N Thaker; Michael L Jackson; Edward A Belongia; Richard K Zimmerman; Manjusha Gaglani; Lois Lamerato; Sarah M Spencer; Lisa Jackson; Jennifer K Meece; Mary Patricia Nowalk; Juhee Song; Marcus Zervos; Po-Yung Cheng; Charles R Rinaldo; Lydia Clipper; David K Shay; Pedro Piedra; Arnold S Monto
Journal:  Clin Infect Dis       Date:  2013-11-13       Impact factor: 9.079

Review 9.  Immunobiology of influenza vaccines.

Authors:  Margarita M Gomez Lorenzo; Matthew J Fenton
Journal:  Chest       Date:  2013-02-01       Impact factor: 9.410

Review 10.  Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients.

Authors:  Arnt-Ove Hovden; Rebecca Jane Cox; Lars Reinhardt Haaheim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.